Sept. 30 – Oct. 2
Convergence Science & Education

ESMRMB 2020 Online Programme

All times given in CEST

The Electronic Poster and Clinical Review Poster Presentations as well as the Lightning Talks are available for on-demand viewing throughout the whole meeting.

View the Lightning Talks here.
View the posters here.

Links to these and access to the streamed sessions has been provided to all registered participants in a mailing on September 29. Please contact the ESMRMB Office at, if you have not received your access information.

The Book of Abstracts 2020 is now available online, you can access it here.



September 30, 2020
Time Room A Time Room B
Translational Trends: What’s Coming to the Clinic?

Chair: C. Faber, Münster/DE, I.M. Nöbauer-Huhmann, Vienna/AT
08:00 Metabolic MRI and MR Spectroscopy
J. Prompers, Utrecht/NL
08:20 Novel Contrasts and Alternatives to Gd
D. Paech, Heidelberg/DE
08:40 Q&A

GREC – Welcome

Chair: A. Rovira, Barcelona/ES
08:00 Welcome and Practical Meeting Issues
A. Rovira, Barcelona/ES
08:05 Introduction by ESMRMB-GREC Chairs
C.C. Quattrocchi, Rome/IT, A. Nederveen, Amsterdam/NL

GREC – 2020 Update on gadolinium research

Chair: A. Nederveen, Amsterdam/NL, C.C. Quattrocchi, Rome/IT
08:10 What is new in gadolinium chemistry & speciation?
S. Aime, Torino/IT, E. Gianolio, Torino/IT
08:25 What is new in gadolinium deposition in brain and body?
A. Radbruch, Bonn/DE
08:40 Q&A

Opening and Plenary Session ‘Sustainable MRI’

Chair: A. Rockall, London/UK, M. Smits, Rotterdam/NL
09:15 Opening Ceremony
A. Rockall, London/UK, M. Smits, Rotterdam/NL
09:25 Sustainability in MRI
A. Webb, Leiden/NL
09:40 Open Source Magnetic Resonance Imaging
L. Winter, Berlin/DE
09:55 Building a Sustainable Diagnostic Imaging Clinic in Subsaharan Africa
A. Fatade, Lagos/NG
10:10 Q&A

Frontiers in Preclinical MRI – Imaging Brain Function & Microstructure

Chair: C. Faber, Münster/DE, J. Klohs, Zurich/CH
10:30 Welcome and Introduction
C. Faber, Münster/DE
10:35 Bridging the Translational Gap in Stroke Research: A Preclinical Perspective
M. Dobrivojevic Radmilovic, Zagreb/HR
10:50 Measuring Network Function in the Mouse Brain with MRI. Principles for Refinement
V. Zerbi, Zurich/CH
11:05 Combining fMRI with electrical recording and stimulation in anesthetized and awake rats
O. Gröhn, Kuopio/FI
11:20 Q&A

GREC – Keynote Lectures

Chair: A. Nederveen, Amsterdam/NL, C.C. Quattrocchi, Rome/IT
10:30 Gadolinium deposition disease. Does it exist?
J. Ramalho, Lisbon/PT
11:00 Intrathecal GBCA for evaluating the glymphatic system and craniospinal molecular clearance
G.A. Ringstad, Oslo/NO
11:30 Q&A

Frontiers in Preclinical MRI – Cardiac Imaging

Chair: C. Faber, Münster/DE, K. Vandoorne, Eindhoven/NL
11:30 Radial 4D Phase-contrast Acquisition Strategies to Quantify and Visualize Blood Flow Hemodynamics in Vivo
V. Hoerr, Münster/DE
11:45 Pushing the Boundaries of Preclinical Cardiac MRI
J. Schneider, Leeds/UK
12:00 Longitudinal in vivo non-invasive multimodal imaging of neuroinflammation and cerebrovascular parameters in experimental stroke and assessment of drug efficiency following the 3R principles
C. Barca, Münster/DE
12:10 In vivo MRI characterization of the Xlf-/- mouse model of genetic radiosensitivity following low-dose in utero irradiation
L. Mouton, Gif sur Yvette/FR
12:20 Q&A

GREC – Gadolinium in the environment

Chair: O. Clement, Paris/FR, C.C. Quattrocchi, Rome/IT
11:50 GBCA in waste / river water
G. Stroomberg, Nieuwegein/NL
12:00 GBCA in drinking water
U. Karst, Münster/DE
12:10 Removal of Gadolinium from the environment
G. Stroomberg, Nieuwegein/NL
12:20 Q&A

Industry Symposium Bruker – Creating the Future of MRI

Creating the Future of MRI
T. Wokrina
News from Bruker Nuclear Molecular Imaging
M. Heidenreich


Frontiers in Preclinical MRI – Cancer Imaging

Chair: C. Faber, Münster/DE, U. Himmelreich, Leuven/BE
14:30 The Role of MRI in Experimental Cancer Models
R. Canese, Rome/IT
14:45 Multimodal Imaging of the Tumour Microenvironment
M. Neeman, Rehovot/IL
15:00 Q&A

GREC – Gadolinium dose reduction / gadolinium-free MRI strategies

Chair: A. Radbruch, Heidelberg/DE, A. Rovira, Barcelona/ES
14:30 Non-Gadolinium based contrast agents
D. Longo, Rome/IT
14:40 GBCAs reduction: the REDUCE study
A. Nederveen, Amsterdam/NL, C. Lavini, Amsterdam/NL
14:50 CNS MRI
T. Granberg, Stockholm/SE
15:00 MSK MRI
J.C. Vilanova, Girona/ES
15:10 Q&A
15:20 Abdominal MRI
M. Ramalho, Almada/PT
15:30 Cardiovascular MRI
T. Leiner, Utrecht/NL
15:40 GBCAs overuse
O. Clement, Paris/FR
15:50 Q&A

Frontiers in Preclinical MRI – Molecular Imaging

Chair: C. Faber, Münster/DE, P. Marzola, Verona/IT
15:10 Inorganic Nanofluorides as Tunable Small-sized Nanotracers for 19F-MRI
A. Bar-Shir, Rehovot/IL
15:25 Parahydrogen Polarized Metabolites for Biological Studies
E. Cavallari, Rome/IT
15:40 Targeting of cancer integrins by using RGD/Gd-Giant Unilamellar vesicles by exploiting Magnetization Transfer Contrast MRI
G. Ferrauto, Rome/IT
15:50 Q&A

GREC – Summary & Conclusions

Chair: A. Nederveen, Amsterdam/NL, C.C. Quattrocchi, Rome/IT
15:50 Adjourn
A. Nederveen, Amsterdam/NL, C.C. Quattrocchi, Rome/IT

Scientific Session – Preclinical MRI

Chair: C. Faber, Münster/DE, K. Vandoorne, Eindhoven/NL
16:30 MRSI-observed pattern changes as immune system activity biomarker: the contribution of microglia/macrophages.
P. Calero-Perez, Cerdanyola del Vallès/ES
16:36 Quantitative assessment of gadolinium-enhancing lesion burden in experimental neuroinflammatory disease using T1 mapping
P. Ramos Delgado, Berlin/DE
16:42 Performance of Compressed Sensing for detecting low SNR 19F MRI in Experimental Autoimmune Encephalomyelitis using Prospective Undersampling
L. Starke, Berlin/DE
16:48 Blood brain barrier opening with mannitol.Impact on brain metabolism, a proton MRS study.
A. Viola, Marseille/FR
16:54 Quantifying different iron forms in aceruloplasminemia brain to explore iron-related neurodegeneration
L. Bossoni, Leiden/NL
17:00 A detailed in vitro and in vivo comparison of D-Glucose and 3-O-Methyl-D-glucose as MRI-CEST contrast agents
A. Anemone, Torino/IT
17:06 Q&A

Improving Clinical and Research Care in MRI

Chair: J. McNulty, Dublin/IE, V. Silva, Porto/PT
16:30 Patient Preparation & Patient Care: Doing Things Better
A. Cradock, Dublin/IE
16:45 Exploring a Child’s Journey: Little Steps with a Big Impact
C. Simcock, London/UK
17:00 Research Volunteers: Are We Doing Enough?
C. Malamateniou, London/UK
17:15 Q&A

GliMR: Convergence in Glioma MR Imaging

Chair: P. Figueiredo, Lisbon/PT, E. Warnert, Rotterdam/NL
17:45 Intro to GliMR COST Action
E. Warnert, Rotterdam/NL
17:55 MRI for Radiation Therapy in Glioma
M.F. Spadea, Catanzaro/IT
18:11 Collaboratively Building Large Neuroimaging Datasets for Glioma Research
C. Maumet, Rennes/FR
18:26 Molecular and Cellular Hallmarks of Brain Tumours: Prognostic & Therapeutic Insights
B. Costa, Braga/PT
18:42 Q&A

Early Career Researchers

Chair: L. Vaclavu, Leiden/NL, M Zhao, Stanford/US
What’s next in your career? It’s a matter of perspective
M. Bright
C. Johnson
Z. Nagy
D. Porter
A. Rakhimova
R. Ramb
M. Willemink

Frontiers in Preclinical MRI – 3Rs

Chair: C. Faber, Münster/DE, U. Himmelreich, Leuven/BE
19:00 Introduction to the 3R principle
A. Mensen, Basel/CH
19:20 Short Presentations
19:30 Open Discussion

Early Career Researchers Committee Drinks


October 1, 2020
Time Room A   Time Room B
MR Safety

Chair: E. Oei, Rotterdam/NL, F. Schick, Tübingen/DE
08:00 A Primer on MR Safety
W. Teeuwisse, Leiden/NL
08:20 Problems in Higher Field & Real-time Assessment
T. Fiedler, Heidelberg/DE
08:40 Q&A

Basic Principles of AI for Acquisition

Chair: B. Poser, Maastricht/NL, N. van den Berg, Utrecht/NL
08:00 Basic Approaches of Using AI for MR Acquisition and Reconstruction
K. Hammernik, London/UK
08:20 Model-based AI image reconstruction in MRI
F. Knoll, New York/US
08:40 Q&A

Plenary Session ‘MR in Translational Medicine’

Chair: C. Faber, Münster/DE, E. Oei, Rotterdam/NL
09:15 DVT: From Bench-side to Bed-side
A. Phinikaridou, London/UK
09:30 Elasticity Imaging: From Fibrosis & Tumor Pressure to Mechanotransduction & Visualizing Primary Neuronal Activity
R. Sinkus, Paris/FR
09:45 Cardiac Perfusion as an Example of Clinical Translation
E. Nagel, Frankfurt/DE
10:00 Q&A

Physiological MRI of MSK Systems

Chair: E. Oei, Rotterdam/NL, I.M. Nöbauer-Huhmann, Vienna/AT
10:30 Cartilage: MR Assessment of Cartilage Quality & Repair Tissue
S. Trattnig, Vienna/AT
10:45 Muscle: Deep Tissue Injury & Avoidance of Pressure Ulcers
G. Strijkers, Amsterdam/NL
11:00 Bone Marrow: Composition & Relation to Diseases
D. Karampinos, Munich/DE
11:15 Q&A

Scientific Session – Acquisition & Reconstruction

Chair: C. Prieto-Vasquez, London/UK, B. Poser, Maastricht/NL
10:30 Filling the ZTE Dead-Time Gap with Parallel Imaging
T. Wood, London/UK
10:36 Fast high-quality and -resolution multi parameter mapping (MPM) at 7 Tesla using skipped-CAIPI 3D-EPI
D. Wang, Bonn/DE
10:42 Regularized joint water/fat separation and B0 map estimation for Echo-Planar Imaging
Y. Dong, Leiden/NL
10:48 Phase-immune multi-shot gradient echo EPI with adiabatic phaseless encoding
C. Sainz Martinez, Zurich/CH
10:54 Towards Simultaneous T1, T2 and T1ρ Magnetic Resonance Fingerprinting for Contrast-free Myocardial Tissue Characterization
C. Velasco, London/UK
11:00 3D Isotropic-resolution Motion Compensated Simultaneous Liver T1, T2 and fat fraction mapping
G. Milotta, London/UK
11:06 Q&A
11:30 High-resolution perfusion and blood-volume fMRI at 7T with simultaneous multi-slice spiral-out acquisitions
D. Kurban, Maastricht/NL
11:36 Fast and quiet MPRAGE using a silent gradient axis
E. Versteeg, Utrecht/NL
11:42 Removal of Magnetization Transfer Contrast for Variable-Delay Multi-Pulse Chemical Exchange Saturation Transfer (VDMP-CEST) imaging of the human brain at 7T
B. Schmitz-Abecassis, Leiden/NL
11:48 Calibration-free static RF shimming for localised MR spectroscopy
A. Berrington, Nottingham/UK
11:54 Deuterium Metabolic Imaging of [2H9]choline simultaneously with that of [6,6 2H2]glucose in tumors
A. Heerschap, Nijmegen/NL
12:00 Readout-segmented COKE: a technique for echo-planar spectroscopic imaging at 7 tesla with high spectral bandwidth and suppression of Nyquist errors in the spectral domain
G. Keith, Glasgow/UK
12:06 Q&A


Chair: E. Oei, Rotterdam/NL, J. Wikström, Uppsala/SE
11:30 AI for MR Image Quality Harmonization and Radiomics Analysis
A. Alberich-Bayarri, Valencia/ES
11:45 Synthetic Imaging for Quantitative MRI
C. Alberola, Valladolid/ES
12:00 Bias in Quantification: Do Existing Tools Offer Comparable Results?
F. Navarro, Málaga/ES
12:15 Q&A

Industry Symposium – GE – Refining Neuro Clinical Management with an Optimised Fast Gradient MR

13:00 Introduction
Fotis Vlachos, PhD – GE Healthcare, Europe
13:02 Upgrading to a high gradient 3.0T MR system: Optimization of the MR protocols for a better clinical patient management
Prof. Damien Galanaud – Hôpital Pitié Salpêtrière, Paris
13:22 Q&A

Industry Symposium – Siemens – Exploring New Frontiers in MRI, Together

Translate 7T research power into clinical care
Nicolas Behl, Siemens Healthineers, Erlangen, Germany
A story of ICE and FIRE: A new prototyping environment for advanced reconstruction and post-processing
Kelvin Chow, Siemens Healthineers, Chicago, USA

Clinical Trends in Neuroimaging

Chair: M. Smits, Rotterdam/NL, M. Tosetti, Pisa/IT
14:30 Cerebral Perfusion Imaging and 4D-MRA Without Contrast Agents
M. Sokolska, London/UK
14:50 CEST: APT and Beyond
D. Paech, Heidelberg/DE
15:10 MRI of Inflammation
M. Cercignani, Sussex/UK
15:30 Q&A

Scientific Session – AI in Action

Chair: E. Scheurer, Basel/CH, M. Zhao, Stanford/US
14:30 A deep-learning approach to accelerated T1-T2-relaxation-correlation imaging
S. Endt, Garching/DE
14:36 Generation of Fully Annotated Abdominal T1-weighted MR Ground Truth Data for Image Segmentation and Registration using CycleGANs and the XCAT Phantom
D.F. Bauer, Mannheim/DE
14:42 Autoencoding T1 using MRzero for simultaneous sequence optimization and neural network training.
H. Nam Dang, Erlangen/DE
14:48 Super Resolution of Dynamic MRI using Deep Learning, Enhanced by Prior-Knowledge
C. Sarasaen, Magdeburg/DE
14:54 Comparison of three B1 correction methods for RARE MRI with transceive surface RF probes
P. Ramos Delgado, Berlin/DE
15:00 Q&A
15:20 Simultaneous Noise Suppression and Edge Preservation in Phase-based MRI Conductivity Mapping
A. Karsa, London/UK
15:26 Comparing the SPIJN algorithm with conventional NNLS for myelin water fraction mapping
R. Berg, Munich/DE
15:32 Towards a Representative Estimation of the MRI-Visible Axon-Radius Distribution using Large-Scale Light Microscopy Images
S. Papazoglou, Hamburg/DE
15:38 Classification of Motion Corrupted Brain MR Images using Deep Learning Techniques
A. Sciarra, Magdeburg/DE
15:44 Q&A

Scientific Session – Clinical Applications of MRI

Chair: R. Manfredi, Rome/IT, A. Webb, Leiden/NL
16:30 Technical recommendations for renal MRI involving ASL, BOLD, DWI, T1 and T2 mapping: a consensus project of the Cooperation in Science and Technology Action PARENCHIMA
I. Dekkers, Voorburg/NL
16:36 Longitudinal Visibility of MRI findings in living Victims of Strangulation
C. Hollenstein, Basel/CH
16:42 Applicator Visualization for High-dose-rate Endorectal Brachytherapy Using Ultrashort Echo Time Imaging
E. Ercan, Leiden/NL
16:48 Muscular fat infiltration in FSHD starts with a “fat burst” near the distal tendon and advances towards the proximal tendon
A. Heerschap, Nijmegen/NL
16:54 Improved therapy planning for eye tumors: a comparison between MRI and conventional ultrasound
L. Klaassen, Leiden/NL
17:00 Preliminary results of application of machine learning to WB-MRI in the staging of colorectal cancer: the MALIBO study
A. Fagan, London/UK
17:06 Q&A

Scientific Session – Interventional MRI

Chair: E. Scheurer, Basel/CH, M. Zaitsev, Vienna/AT
16:30 Specific absorption rate in a dedicated birdcage coil for neonatal MRI
R. Kowal, Magdeburg/DE
16:36 MRI-guided ultrasound therapy to overcome the chemotherapy resistance in ovarian cancer
D. Patrucco, Torino/IT
16:42 3D brain imaging at 50 mT in a Halbach-based permanent magnet MRI scanner
T. O’Reilly, Leiden/NL
16:48 32-Channel Lightweight Dipole RF Array for Cardiac MRI at 7.0 Tesla
T. Wilhelm Eigentler, Berlin/DE
16:54 Metamaterial inspired volumetric resonator for targeted MRI of the breast at 1.5T
V. Puchnin, St. Petersburg/RU
17:00 RF safety evaluation of an 8-channel dipole array for neonatal brain and cardiac MR at 7T parallel-transmit
J. Clément, London/UK
17:06 Q&A

CAMERA – Working Group Meeting

Chair: U. Anazodo, London/UK, A. Webb, Leiden/NL

17:45 Introduction to CAMERA
U. Anazodo, London/CA
17:55 Doing Much with little: Benefits and Challenges of Low Field MRI in Africa
G. Ogbole, Ibadan/NG
18:07 Expanding the Imaging Enterprise and Implementation of Artificial Intelligence in Africa
F. Dako, Pennsylvania/USA
18:19 Installation of an MRI system in Mozambique – Implementation, difficulties, and impact
M.F. Forjaz Secca, Maputo/MZ
18:32 – Q & A and panel discussion

Collaboration Session – renal MRI, PARENCHIMA

Chair: E. Scheurer, Basel/CH, M. Wolf, Vienna/AT
17:45 Introduction to PARENCHIMA (
M. Wolf, Vienna/AT
17:55 Renal Physiology in a Nutshell: How do Kidneys Work and What Causes Kidney Damage?
M. Pruijm, Lausanne/CH
18:07 Repeatability and Sensitivity of MRI Biomarkers of CKD, Relation to GFR and UACR
I. Friedli, Mölndal/SE
18:19 BOLD-MRI: A Breath of Fresh Air in the Study of Kidney Diseases
M. Pruijm, Lausanne/CH
18:31 Pre-transplant Kidney Assessment 2.0 – Are We Ready?
C. Moers, Groningen/NL
18:43 Translating Functional Renal MRI into Clinical Practice: A Historical Evolution
D. Pendse, London/UK
18:55 Q&A

October 2, 2020
Time Room A   Time Room B
Real-time Imaging

Chair: R. Bowtell, Nottingham/UK, M. Zaitsev, Vienna/AT
08:00 Intraoperative Imaging & Image-Guided Therapy
B. Quesson, Bordeaux/FR
08:20 Undersampling & Reconstruction Strategies for Fast Imaging in Interventional MRI
C. Kolbitsch, Berlin/DE
08:40 Q&A

Assessment of AI Tools & Public Datasets

Chair: M. Blackledge, London/UK, D. Sappey-Marinier, Lyon/FR
08:00 Introduction of AI for Radiology into Clinical Practice
A. Andreychenko, Moscow/RU
08:20 AI in Radiology: State-of-the-Art and Future Needs
G. Langs, Vienna/AT
08:40 Q&A

Plenary Session ‘Evolving Therapy Options with MRI’

Chair: R. Bowtell, Nottingham/UK, N. van den Berg, Utrecht/NL
09:15 Hardware Design for MR-guided Therapy
J. Overweg, Hamburg/DE
09:30 MRI techniques for MR-guided Therapy
C. Moonen, Utrecht/NL
09:45 Clinical Impact of MR-guided Therapy
R. Razavi, London/UK
10:00 Q&A

Artefacts incl. Metal: Challenges & Solutions

Chair: R. Bowtell, Nottingham/UK, E. Oei, Rotterdam/NL
10:30 Concepts and MR Strategies to Minimize Metal Artefacts
M. Nittka, Erlangen/DE
10:45 A Radiologist’s Perspective on Metal Artefacts & Implants
R. Sutter, Zurich/CH
11:00 Metal & RF: Safety Issues
T. Owman, Lund/SE
11:15 Q&A

Scientific Session – Brain & fMRI

Chair: S. Assili, Oulu/FI, B. Poser, Maastricht/NL
10:30 Measuring cerebrovascular reactivity in patients with Moyamoya Disease: Comparison of resting-state BOLD fMRI to breath-hold BOLD fMRI
L. Zerweck, Tübingen/DE
10:36 Postmortem Temperature and its Effect on Quantitative Magnetic Resonance Imaging
C. Berger, Basel/CH
10:42 Intracellular Water Lifetime: a new in vivo biomarker of glioma cell invasion/migration by FFC NMR relaxometry
M.R. Ruggiero, Torino/IT
10:48 Perfusion imaging with Arterial Spin Labeling (ASL)-MRI predicts malignant progression in low-grade (WHO grade II) gliomas
C.M. Flies, Utrecht/NL
10:54 Variations in Brain Magnetic Susceptibility in Sickle Cell Anaemia
R. Murdoch, London/UK
11:00 Increased cerebrovascular reactivity during spontaneous migraine attacks compared to pain-free periods
S. Cotrim, Lisbon/PT
11:06 Q&A
11:30 fMRI brain activation during a novel VR-based motor imagery and observation task: comparison with a conventional motor imagery task
J. Nunes, Lisbon/PT
11:36 Spiral in/out trajectory with GIRF prediction for passband bSSFP fMRI at 7T
M. Veldmann, Bonn/DE
11:42 Arterial blood contrast (ABC) enabled by magnetization transfer (MT): a novel MRI technique for enhancing the measurement of brain activation changes beyond BOLD
J. Schulz, Nijmegen/NL
11:48 Abnormal Dynamic Functional Connectivity State in Cerebral Small Vessel Disease
M. Palma, Lisbon/PT
11:54 Comparison between pulsed and pseudo-continuos arterial spin labeling with single-shot 3D GRASE readout for fMRI at 3T
D. Ivanov, Maastricht/NL
12:00 Proton MRS of the foetal brain at 3T : normality
A. Viola, Marseille/FR
12:06 Q&A

Response Prediction with MR

Chair: M. Blackledge, London/UK, M. Tosetti, Pisa/IT
11:30 Imaging MR Biomarkers in Oncology
M. McLean, Cambridge/UK
11:50 7T MR: The Future Chemical Imaging Tool for Therapy
J. Wijnen, Utrecht/NL
12:10 Q&A


Industry Symposium PHILIPS – Partnering to Deliver Speed, Comfort and Confidence

Chair: Allison Stroud
13:00 Introduction
A. Stroud
13:05 Increasing the speed of MRI by AI-based reconstructions
Matthias van Osch
13:25 Quantitative MRI in clinical practice
Jonathan R. Dillmann
13:45 Closing

Motion & Artefacts in the Chest & Abdomen

Chair: C. Prieto-Vasquez, London/UK, J.C. Vilanova, Girona/ES
14:30 Update: Physical Principles to Freeze Physiologic Motion
T. Küstner, Tübingen/DE
14:50 Cardiac & Chest MRI
C. Beigelmann-Aubry, Lausanne/CH
15:10 Motion in the Abdomen & Pelvis
R. Manfredi, Rome/IT
15:30 Q&A

Scientific Session – Diffusion & Perfusion

Chair: P. Figueiredo, Lisbon/PT, M. van Osch, Leiden/NL
14:30 Investigating the white matter compartmental R2 orientational anisotropy
E. Kleban, Cardiff/UK
14:36 A novel superficial white matter connectivity atlas of the chimpanzee brain
M. Chauvel, Gif-Sur-Yvette/FR
14:42 Abbreviated DWI protocol for Gaussian and Non-Gaussian diffusion: Application to an Alzheimer mouse model
R. Golgolab, Gif-Sur-Yvette/FR
14:48 Relationship between R2(*) Relaxation and Gd-DTPA Concentration in Whole Blood Assessed by Simulations
D. van Dorth, Leiden/NL
14:54 Exchange time as a proxy measure of blood brain barrier integrity – A two-stage estimation
A. Mahroo, Bremen/DE
15:00 Q&A
15:20 Feasibility of Spatio-temporal Encoding for Arterial Spin Labelling at location with strong magnetic field inhomogeneities
M. Schuurmans, Utrecht/NL
15:26 Evaluation of treatment efficacy in asymptomatic carotid artery stenosis patients by clinically applicable hemodynamic MRI and cognitive testing
S. Kaczmarz, Munich/DE
15:32 Comparing The Repeatability of Cerebrovascular Reactivity Measurements Using PET/MRI
M. Zhao, Stanford/US
15:38 Comparison of Diffusion-weighted Imaging (DWI), Perfusion-weighted imaging (PWI) and MR spectroscopy (MRS) as a biomarkers for therapy response after stereotactic radiosurgery in patients with recurrent glioblastoma multiforme (GBM): our experience.
P.P. Arcuri, Catanzaro/IT
15:44 Q&A

Roundtable Discussion: Convergence in MRI

Chair: G. Langs, Vienna/AT

Panellists: M. Vidorreta, Madrid/ES
S. Punwani, London/UK
L.-A. Harsan, Strasbourg/FR
J.A. Hernandez-Tamames, Rotterdam/NL